Hakimian, M. and Noori, R. (2018) “The relationship between Pembrolizumab for the treatment of PD-L1 positive advanced in cell lung cancer”, International Pharmacy Acta, 1(1), pp. 154–154. doi: 10.22037/ipa.v1i1.20499.